<p>北达科他州投资委员会在第四季度收购了 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的新头寸，具体信息来自其最近向证券交易委员会（SEC）提交的文件。该公司收购了 43,833 股该药房运营商的股票，价值约为 3,479,000 美元。</p>
<ul>
<li>3 只医疗保健股票将受益于这项重大法案</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也增加或减少了在该公司的持股。Alteri Wealth LLC 在第三季度将其在 CVS Health 的持股增加了 3.2%。Alteri Wealth LLC 目前拥有 4,195 股该药房运营商的股票，价值 316,000 美元，在此期间又购买了 131 股。TOWER TRUST &amp; INVESTMENT Co 在第四季度将其在 CVS Health 的持股增加了 0.8%。TOWER TRUST &amp; INVESTMENT Co 目前拥有 15,708 股该药房运营商的股票，价值 1,247,000 美元，在此期间又购买了 132 股。Holistic Financial Partners 在第三季度将其在 CVS Health 的持股增加了 4.1%。Holistic Financial Partners 目前拥有 3,397 股该药房运营商的股票，价值 256,000 美元，在此期间又收购了 133 股。CYBER HORNET ETFs LLC 在第三季度将其在 CVS Health 的持股增加了 4.1%。CYBER HORNET ETFs LLC 目前拥有 3,442 股该药房运营商的股票，价值 259,000 美元，在此期间又收购了 134 股。最后，LS Investment Advisors LLC 在第四季度将其在 CVS Health 的持股增加了 3.9%。LS Investment Advisors LLC 目前拥有 3,575 股该药房运营商的股票，价值 284,000 美元，在此期间又收购了 135 股。当前 80.66% 的股票由机构投资者和对冲基金持有。</p>
<h2>华尔街分析师观点</h2>
<p>多位分析师对该股票发表了评论。德意志银行将 CVS Health 的目标股价从 88.00 美元上调至 92.00 美元，并在 5 月 7 日的报告中给予该股票 “买入” 评级。高盛集团将 CVS Health 的目标股价从 95.00 美元上调至 97.00 美元，并在 2 月 12 日的研究报告中给予该股票 “买入” 评级。美国银行将 CVS Health 的目标股价从 100.00 美元下调至 95.00 美元，并在 1 月 27 日的研究报告中为该公司设定了 “买入” 评级。Sanford C. Bernstein 将 CVS Health 的目标股价从 94.00 美元上调至 106.00 美元，并在 5 月 12 日的研究报告中给予该股票 “跑赢大盘” 评级。最后，Wall Street Zen 在 5 月 9 日的研究报告中将 CVS Health 的评级从 “持有” 上调至 “买入”。22 位投资分析师对该股票给予了 “买入” 评级，4 位给予了 “持有” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标股价为 98.08 美元。</p>
<ul>
<li>这只 ETF 证明医疗保健复苏是真实的</li>
</ul>
<p><strong>查看我们关于 CVS 的最新报告</strong></p>
<h2>CVS Health 价格表现</h2>
<p>CVS 股票周一开盘价为 95.95 美元。CVS Health Corporation 的 12 个月低点为 58.50 美元，12 个月高点为 98.43 美元。该公司的市值为 1,224.2 亿美元，市盈率为 42.27，市盈增长比率为 0.94，贝塔值为 0.60。该公司的速动比率为 0.66，流动比率为 0.87，债务股本比率为 0.78。该公司的 50 日移动平均线为 78.71 美元，200 日移动平均线为 78.57 美元。</p>
<ul>
<li>CVS Health 在收入增长和股息保持强劲的情况下获利</li>
</ul>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近在 5 月 6 日发布了季度财报。该药房运营商报告每股收益（EPS）为 2.57 美元，超出市场共识预期的 2.21 美元，超出幅度为 0.36 美元。CVS Health 的股本回报率为 11.88%，净利润率为 0.72%。该公司在本季度的收入为 1,004.3 亿美元，而分析师预期为 949.9 亿美元。在去年同期，该公司每股收益为 2.25 美元。CVS Health 的季度收入较去年同期增长了 6.2%。CVS Health 已将其 2026 财年的指引设定为每股收益在 7.300-7.500 之间。平均而言，股票研究分析师预测 CVS Health Corporation 在当前年度将发布每股收益 7.44 美元。</p>
<h2>CVS Health 宣布分红</h2>
<p>该公司最近还披露了季度分红，已于 5 月 4 日支付。4 月 23 日的登记投资者获得了 0.665 美元的分红。除息日期为 4 月 23 日。这代表着每年 2.66 美元的分红和 2.8% 的股息收益率。CVS Health 的派息比率目前为 117.18%。</p>
<h2>内部交易活动</h2>
<p>在相关消息中，执行副总裁 Tilak Mandadi 于 5 月 8 日出售了 69,551 股公司的股票。该股票的平均售价为 89.58 美元，总价值为 6,230,378.58 美元。交易完成后，该执行副总裁直接持有公司 10,133 股，价值约为 907,714.14 美元。此次交易使其持股减少了 87.28%。该出售在向证券交易委员会提交的文件中披露，可以通过此链接访问。公司内部人士持有公司股票的 0.85%。</p>
<h2>CVS Health 新闻汇总</h2>
<p>以下是本周影响 CVS Health 的主要新闻故事：</p>
<ul>
<li>积极情绪：摩根士丹利上调了对 CVS Health 的目标股价，并维持了增持评级，表明对公司超出预期的季度业绩后进一步上涨的信心。摩根士丹利对 CVS Health 发布积极预测 NYSE: CVS 股价</li>
<li>积极情绪：Argus 也提升了对 CVS Health 的展望，进一步增加了分析师支持的浪潮，这可能帮助股价上涨。Argus 对 CVS Health 发布积极预测 NYSE: CVS 股价</li>
<li>积极情绪：CVS 最近公布了 2026 年第一季度的强劲业绩，收入和调整后每股收益均超出预期，这继续推动投资者对执行和估值的乐观情绪。以下是为什么 CVS Health (CVS) 是未来 10 年值得购买的便宜股票</li>
<li>积极情绪：CVS 与 WGU 推出了一项在线药学预科学位项目，以帮助建立更强大的药剂师人才管道，这一举措可能支持长期的人力资源和服务增长。CVS Health®与 WGU 推出全国未来药剂师的在线药学预科项目</li>
<li>中性情绪：CVS 通过在破产法庭批准后出售 Omnicare，推进了其投资组合重组，这简化了业务并剔除了一个表现不佳的单位，但也确认了持续的重组。CVS 通过 Omnicare 出售和无人机推广重新聚焦核心健康平台</li>
<li>中性情绪：CVS 还强调了在罗德岛的社区和品牌建设举措，包括其经济影响报告和扩大 WIC 接受度，这对声誉是积极的，但不太可能单独推动股价。CVS Health 在罗德岛的年度影响</li>
</ul>
<h2>关于 CVS Health</h2>
<p>（免费报告）</p>
<p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛的伍恩索克特，追溯到 20 世纪 60 年代初，已发展成为一个综合的处方药、非处方产品、临床服务和健康保险提供商。其运营模式结合了零售药房位置和店内诊所，以及更广泛的药房和健康计划能力。</p>
<p>主要业务活动包括 CVS 药房零售运营、MinuteClinic 步入式医疗诊所和提供扩展临床服务的 HealthHUB 地点。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>Robinhood、SoFi 和 Webull 讲述截然不同的故事</li>
<li>当博通市值超过 2 万亿美元时，私人信贷巨头想要参与</li>
<li>通过这些 ETF 瞄准火热的分拆和合并领域</li>
<li>随着 AI 内存需求激增，三星加入 1 万亿美元俱乐部</li>
</ul>
<p><strong>想看看其他对 CVS 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com，获取 CVS Health Corporation (NYSE:CVS - 免费报告) 的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，以便在更广泛的市场注意到之前购买……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

最新一批13F持仓出炉：伯克希尔Q1加仓谷歌A类超200%，跃升至第七大重仓股；彻底清仓持有近七年的亚马逊以及Visa、万事达、联合健康，并时隔六年重新杀回航空股，斥资26.5亿美元建仓达美航空。桥水则首次建仓台积电与黄金ETF（GLD），加仓亚马逊（升至第一大重仓股）、英伟达、博通、美光；同时清仓赛富时、ServiceNow，减持万事达、Adobe等。机构资金正集中流向AI算力与避险资产。你的持仓里，有几只被巨头点名？

<p>最新一批13F持仓出炉：伯克希尔Q1加仓谷歌A类超200%，跃升至第七大重仓股；彻底清仓持有近七年的亚马逊以及Visa、万事达、联合健康，并时隔六年重新杀回航空股，斥资26.5亿美元建仓达美航空。桥水则首次建仓台积电与黄金ETF（GLD），加仓亚马逊（升至第一大重仓股）、英伟达、博通、美光；同时清仓赛富时、ServiceNow，减持万事达、Adobe等。机构资金正集中流向AI算力与避险资产。你的持仓里，有几只被巨头点名？</p>

巨头13F出炉：押注AI算力与避险

西维斯

<p>根据 SEC 的文件，北达科他州投资委员会在第四季度收购了 43,833 股 CVS Health Corporation（纽约证券交易所代码：CVS），价值约 348 万美元。其他机构投资者也调整了他们在 CVS 的持股。分析师对 CVS 给予了 “适度买入” 的评级，目标价格范围在 92 美元到 106 美元之间。CVS 报告第一季度每股收益为 2.57 美元，超出预期，收入为 1004.3 亿美元，同比增长 6.2%</p>

<p>North Dakota State Investment Board acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 43,833 shares of the pharmacy operator's stock, valued at approximately $3,479,000.</p>
<div class="lb-trans"><p>北达科他州投资委员会在第四季度收购了 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的新头寸，具体信息来自其最近向证券交易委员会（SEC）提交的文件。该公司收购了 43,833 股该药房运营商的股票，价值约为 3,479,000 美元。</p>
</div><ul>
<li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只医疗保健股票将受益于这项重大法案</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Alteri Wealth LLC increased its position in CVS Health by 3.2% in the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator's stock worth $316,000 after purchasing an additional 131 shares during the period. TOWER TRUST &amp; INVESTMENT Co increased its position in CVS Health by 0.8% in the fourth quarter. TOWER TRUST &amp; INVESTMENT Co now owns 15,708 shares of the pharmacy operator's stock worth $1,247,000 after purchasing an additional 132 shares during the period. Holistic Financial Partners grew its holdings in CVS Health by 4.1% during the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator's stock worth $256,000 after acquiring an additional 133 shares during the period. CYBER HORNET ETFs LLC grew its holdings in CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator's stock worth $259,000 after acquiring an additional 134 shares during the period. Finally, LS Investment Advisors LLC grew its holdings in CVS Health by 3.9% during the 4th quarter. LS Investment Advisors LLC now owns 3,575 shares of the pharmacy operator's stock worth $284,000 after acquiring an additional 135 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也增加或减少了在该公司的持股。Alteri Wealth LLC 在第三季度将其在 CVS Health 的持股增加了 3.2%。Alteri Wealth LLC 目前拥有 4,195 股该药房运营商的股票，价值 316,000 美元，在此期间又购买了 131 股。TOWER TRUST &amp; INVESTMENT Co 在第四季度将其在 CVS Health 的持股增加了 0.8%。TOWER TRUST &amp; INVESTMENT Co 目前拥有 15,708 股该药房运营商的股票，价值 1,247,000 美元，在此期间又购买了 132 股。Holistic Financial Partners 在第三季度将其在 CVS Health 的持股增加了 4.1%。Holistic Financial Partners 目前拥有 3,397 股该药房运营商的股票，价值 256,000 美元，在此期间又收购了 133 股。CYBER HORNET ETFs LLC 在第三季度将其在 CVS Health 的持股增加了 4.1%。CYBER HORNET ETFs LLC 目前拥有 3,442 股该药房运营商的股票，价值 259,000 美元，在此期间又收购了 134 股。最后，LS Investment Advisors LLC 在第四季度将其在 CVS Health 的持股增加了 3.9%。LS Investment Advisors LLC 目前拥有 3,575 股该药房运营商的股票，价值 284,000 美元，在此期间又收购了 135 股。当前 80.66% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of analysts have commented on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CVS Health from $88.00 to $92.00 and gave the stock a &#34;buy&#34; rating in a report on Thursday, May 7th. The Goldman Sachs Group boosted their target price on CVS Health from $95.00 to $97.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, February 12th. Bank of America decreased their target price on CVS Health from $100.00 to $95.00 and set a &#34;buy&#34; rating for the company in a research report on Tuesday, January 27th. Sanford C. Bernstein boosted their target price on CVS Health from $94.00 to $106.00 and gave the stock an &#34;outperform&#34; rating in a research report on Tuesday, May 12th. Finally, Wall Street Zen upgraded CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, May 9th. Twenty-two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and an average target price of $98.08.</p>
<div class="lb-trans"><p>多位分析师对该股票发表了评论。德意志银行将 CVS Health 的目标股价从 88.00 美元上调至 92.00 美元，并在 5 月 7 日的报告中给予该股票 “买入” 评级。高盛集团将 CVS Health 的目标股价从 95.00 美元上调至 97.00 美元，并在 2 月 12 日的研究报告中给予该股票 “买入” 评级。美国银行将 CVS Health 的目标股价从 100.00 美元下调至 95.00 美元，并在 1 月 27 日的研究报告中为该公司设定了 “买入” 评级。Sanford C. Bernstein 将 CVS Health 的目标股价从 94.00 美元上调至 106.00 美元，并在 5 月 12 日的研究报告中给予该股票 “跑赢大盘” 评级。最后，Wall Street Zen 在 5 月 9 日的研究报告中将 CVS Health 的评级从 “持有” 上调至 “买入”。22 位投资分析师对该股票给予了 “买入” 评级，4 位给予了 “持有” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，平均目标股价为 98.08 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这只 ETF 证明医疗保健复苏是真实的</li>
</ul>
</div><p><strong>Check Out Our Latest Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CVS 的最新报告</strong></p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 价格表现</h2>
</div><p>Shares of CVS stock opened at $95.95 on Monday. CVS Health Corporation has a 12-month low of $58.50 and a 12-month high of $98.43. The firm has a market capitalization of $122.42 billion, a price-to-earnings ratio of 42.27, a price-to-earnings-growth ratio of 0.94 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. The firm has a fifty day moving average of $78.71 and a 200-day moving average of $78.57.</p>
<div class="lb-trans"><p>CVS 股票周一开盘价为 95.95 美元。CVS Health Corporation 的 12 个月低点为 58.50 美元，12 个月高点为 98.43 美元。该公司的市值为 1,224.2 亿美元，市盈率为 42.27，市盈增长比率为 0.94，贝塔值为 0.60。该公司的速动比率为 0.66，流动比率为 0.87，债务股本比率为 0.78。该公司的 50 日移动平均线为 78.71 美元，200 日移动平均线为 78.57 美元。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 在收入增长和股息保持强劲的情况下获利</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. During the same period in the previous year, the firm earned $2.25 EPS. CVS Health's quarterly revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, equities research analysts forecast that CVS Health Corporation will post 7.44 earnings per share for the current year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近在 5 月 6 日发布了季度财报。该药房运营商报告每股收益（EPS）为 2.57 美元，超出市场共识预期的 2.21 美元，超出幅度为 0.36 美元。CVS Health 的股本回报率为 11.88%，净利润率为 0.72%。该公司在本季度的收入为 1,004.3 亿美元，而分析师预期为 949.9 亿美元。在去年同期，该公司每股收益为 2.25 美元。CVS Health 的季度收入较去年同期增长了 6.2%。CVS Health 已将其 2026 财年的指引设定为每股收益在 7.300-7.500 之间。平均而言，股票研究分析师预测 CVS Health Corporation 在当前年度将发布每股收益 7.44 美元。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣布分红</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health's payout ratio is currently 117.18%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，已于 5 月 4 日支付。4 月 23 日的登记投资者获得了 0.665 美元的分红。除息日期为 4 月 23 日。这代表着每年 2.66 美元的分红和 2.8% 的股息收益率。CVS Health 的派息比率目前为 117.18%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In related news, EVP Tilak Mandadi sold 69,551 shares of the business's stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president directly owned 10,133 shares in the company, valued at approximately $907,714.14. The trade was a 87.28% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.85% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Tilak Mandadi 于 5 月 8 日出售了 69,551 股公司的股票。该股票的平均售价为 89.58 美元，总价值为 6,230,378.58 美元。交易完成后，该执行副总裁直接持有公司 10,133 股，价值约为 907,714.14 美元。此次交易使其持股减少了 87.28%。该出售在向证券交易委员会提交的文件中披露，可以通过此链接访问。公司内部人士持有公司股票的 0.85%。</p>
</div><h2>CVS Health News Roundup</h2>
<div class="lb-trans"><h2>CVS Health 新闻汇总</h2>
</div><p>Here are the key news stories impacting CVS Health this week:</p>
<div class="lb-trans"><p>以下是本周影响 CVS Health 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Morgan Stanley raised its price target on CVS Health and kept an overweight rating, signaling confidence in further upside after the company’s stronger-than-expected quarterly results. Morgan Stanley Issues Positive Forecast for CVS Health NYSE: CVS Stock Price</li>
<li>Positive Sentiment: Argus also lifted its outlook for CVS Health, adding to the wave of analyst support that may be helping shares move higher. Argus Issues Positive Forecast for CVS Health NYSE: CVS Stock Price</li>
<li>Positive Sentiment: CVS reported solid Q1 2026 earnings recently, beating estimates on both revenue and adjusted EPS, which continues to drive investor optimism about execution and valuation. Here is Why CVS Health (CVS) is One of the Cheap Stocks to Buy For the Next 10 Years</li>
<li>Positive Sentiment: CVS and WGU launched an online pre-pharmacy degree program to help build a stronger pharmacist pipeline, a move that could support long-term staffing and service growth. CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide</li>
<li>Neutral Sentiment: CVS advanced its portfolio reset by selling Omnicare after bankruptcy court approval, which simplifies the business and removes an underperforming unit, but also confirms ongoing restructuring. CVS Refocuses On Core Health Platform With Omnicare Sale And Drone Rollout</li>
<li>Neutral Sentiment: CVS also highlighted community and brand-building initiatives in Rhode Island, including its economic impact report and expanded WIC acceptance, which are positive for reputation but less likely to move the stock on their own. CVS Health’s Annual Impact in Rhode Island</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：摩根士丹利上调了对 CVS Health 的目标股价，并维持了增持评级，表明对公司超出预期的季度业绩后进一步上涨的信心。摩根士丹利对 CVS Health 发布积极预测 NYSE: CVS 股价</li>
<li>积极情绪：Argus 也提升了对 CVS Health 的展望，进一步增加了分析师支持的浪潮，这可能帮助股价上涨。Argus 对 CVS Health 发布积极预测 NYSE: CVS 股价</li>
<li>积极情绪：CVS 最近公布了 2026 年第一季度的强劲业绩，收入和调整后每股收益均超出预期，这继续推动投资者对执行和估值的乐观情绪。以下是为什么 CVS Health (CVS) 是未来 10 年值得购买的便宜股票</li>
<li>积极情绪：CVS 与 WGU 推出了一项在线药学预科学位项目，以帮助建立更强大的药剂师人才管道，这一举措可能支持长期的人力资源和服务增长。CVS Health®与 WGU 推出全国未来药剂师的在线药学预科项目</li>
<li>中性情绪：CVS 通过在破产法庭批准后出售 Omnicare，推进了其投资组合重组，这简化了业务并剔除了一个表现不佳的单位，但也确认了持续的重组。CVS 通过 Omnicare 出售和无人机推广重新聚焦核心健康平台</li>
<li>中性情绪：CVS 还强调了在罗德岛的社区和品牌建设举措，包括其经济影响报告和扩大 WIC 接受度，这对声誉是积极的，但不太可能单独推动股价。CVS Health 在罗德岛的年度影响</li>
</ul>
</div><h2>About CVS Health</h2>
<div class="lb-trans"><h2>关于 CVS Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛的伍恩索克特，追溯到 20 世纪 60 年代初，已发展成为一个综合的处方药、非处方产品、临床服务和健康保险提供商。其运营模式结合了零售药房位置和店内诊所，以及更广泛的药房和健康计划能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要业务活动包括 CVS 药房零售运营、MinuteClinic 步入式医疗诊所和提供扩展临床服务的 HealthHUB 地点。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Robinhood, SoFi, and Webull Are Telling Very Different Stories</li>
<li>As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In</li>
<li>Target the Red-Hot Spin-Off and Merger Space With These ETFs</li>
<li>Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>Robinhood、SoFi 和 Webull 讲述截然不同的故事</li>
<li>当博通市值超过 2 万亿美元时，私人信贷巨头想要参与</li>
<li>通过这些 ETF 瞄准火热的分拆和合并领域</li>
<li>随着 AI 内存需求激增，三星加入 1 万亿美元俱乐部</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CVS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 CVS 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com，获取 CVS Health Corporation (NYSE:CVS - 免费报告) 的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，以便在更广泛的市场注意到之前购买……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

43,833 Shares in CVS Health Corporation $CVS Purchased by North Dakota State Investment Board

Market Beat

德意志银行

高盛

美国银行

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

GS Hldg R

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

北达科他州投资委员会购入了 CVS Health Corporation（股票代码：$CVS）的 43,833 股股票